InvestorsHub Logo
Followers 43
Posts 3041
Boards Moderated 1
Alias Born 08/09/2006

Re: lefty18 post# 189

Wednesday, 10/06/2010 2:04:27 PM

Wednesday, October 06, 2010 2:04:27 PM

Post# of 1605
I should restate that part about something concrete to go on. There is something concrete here to definitely justify buying more at this price. I was specifically meaning that the company is not releasing any info.

The buying action over the last few months coupled with the past history of the stock definitely signal a buy. Very little selling in this range combined with past spikes in buying that led to the stock reaching the .20s and .40s in recent years is what makes this an attractive buy at this price.

Add that with the reported success of the previous melanoma trial, the complete response of one of the patients of the previous Phase I ovarian cancer trial, the FDA's approval of dendreon's provenge using a very similar treatment, and NWBO's seeming success with it's brain cancer treatment.

It all adds up to a buy.